FGF10 is known to protect neurons against oxygen-glucose deprivation injury in vitro, and FGF10 treatment depressed the triggered inflammatory factors of the TNF-α, IL-6, and nuclear factor-κB signaling pathways in a mouse middle cerebral artery occlusion model [29]. Here, FGF10 is linked to medical procedure.